San Francisco, CA, United States of America

Jacqueline Yvonne Tyler

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Genentech, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacqueline Yvonne Tyler. Retrieved from https://idiyas.com/inventor/jacqueline-yvonne-tyler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacqueline Yvonne Tyler: Innovator in Pharmaceutical Compositions

Introduction

Jacqueline Yvonne Tyler is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly with her work on innovative compositions and methods of use.

Latest Patents

Jacqueline holds 1 patent for her invention titled "Pharmaceutical compositions of mosunetuzumab and methods of use." This patent discloses pharmaceutical compositions that comprise mosunetuzumab and outlines methods for utilizing these compositions effectively.

Career Highlights

Jacqueline is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. Her work at Genentech has allowed her to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

One of her notable coworkers is Junyan Ji, with whom she collaborates on various projects within the company.

Conclusion

Jacqueline Yvonne Tyler's contributions to pharmaceutical innovations exemplify her dedication to advancing medical science. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…